On May 8, 2007, one of the best-known quality measures in healthcare was put to rest. The percentage of patients with acutemyocardial infarction who receive a prescription for beta-blockerswithin 7 days of hospital discharge has been used to evaluateU.S. managed care plans since 1996. This measure will no longerbe reported by the National Committee for Quality Assurance(NCQA) because it is simply no longer needed — a developmentthat offers encouragement and important lessons.
The data in the graph show why the NCQA Committee on PerformanceMeasurement voted unanimously to retire the beta-blocker measure.A . . . [Full Text of this Article]
Source Information
Dr. Lee is network president at Partners Healthcare System, Boston, cochair of the Committee on Performance Measurement for the National Committee for Quality Assurance, and an associate editor of the Journal.
This article has been cited by other articles:
Landon, B. E., Normand, S.-L. T.
(2008). Not Sold on Performance Measures. ANN INTERN MED
149: 146-147
[Full Text]
Dougherty, D., Conway, P. H.
(2008). The "3T's" Road Map to Transform US Health Care: The "How" of High-Quality Care. JAMA
299: 2319-2321
[Full Text]
Meinert, C. L
(2008). Long-term drug prevention trials. Clin Trials
5: 168-176
[Abstract]
Tosi, L. L., Gliklich, R., Kannan, K., Koval, K. J.
(2008). The American Orthopaedic Association's "Own the Bone" Initiative to Prevent Secondary Fractures. JBJS
90: 163-173
[Abstract][Full Text]